Physician
Ochsner Clinic LLC
Ochsner Clinic LLC was paid $152.47M by Medicaid between Jan 2018 and Dec 2024, across 477 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.
33Billing provider infoOCHSNER CLINIC LLC
NEW ORLEANS, LA 70121
NEW ORLEANS, LA 70121
33aNPI1538151428assigned 08/17/2005
33bProvider typeSurgery Physician
28Total paid$152.47M
24GClaims5,935,206
24DCodes billed477
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in Louisiana
Rank by total paid#1 of 65
Median peer was paid$28K
This provider vs. median5,427×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 542,073 | $18.84M | |
| 2019 | 596,337 | $21.65M | |
| 2020 | 537,395 | $19.76M | |
| 2021 | 667,767 | $23.98M | |
| 2022 | 1,320,385 | $24.50M | |
| 2023 | 1,267,766 | $24.56M | |
| 2024incomplete | 1,003,483 | $19.19M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 617,043 | 562,999 | $32.91M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 577,204 | 496,035 | $23.00M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.5% | 150,550 | 52,214 | $6.86M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.3% | 87,096 | 82,387 | $6.50M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 60,684 | 56,454 | $5.13M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.3% | 92,874 | 87,337 | $4.97M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 56,402 | 48,399 | $3.49M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 52,661 | 47,815 | $3.18M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.1% | 83,449 | 73,080 | $3.17M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.9% | 83,969 | 36,301 | $2.85M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.8% | 39,096 | 37,258 | $2.67M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 62,531 | 56,892 | $2.55M |
465 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 52,226 | $2.48M |
| 99285 | Emergency room visit (most serious) | 1.4% | 24,985 | $2.18M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 37,025 | $2.03M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.2% | 389,606 | $1.87M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 55,557 | $1.83M |
| 99223 | Prolong inpt eval add15 m | 1.1% | 23,042 | $1.73M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 25,270 | $1.46M |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 15,707 | $1.32M |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 6,773 | $1.30M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12,297 | $1.22M |
| 71045 | Radiologic examination, chest; single view | <1% | 277,730 | $1.12M |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 38,588 | $1.08M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 35,422 | $1.03M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 6,769 | $1.01M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 14,613 | $994K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 15,473 | $950K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 36,574 | $921K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 37,395 | $916K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 14,455 | $907K |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | <1% | 4,529 | $903K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 15,841 | $823K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 10,190 | $792K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 97,086 | $783K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 17,432 | $776K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 3,000 | $761K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 27,224 | $673K |
| 99205 | Prolong outpt/office vis | <1% | 6,148 | $652K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 21,933 | $599K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 5,972 | $543K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15,555 | $534K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 7,092 | $533K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 9,908 | $529K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 6,659 | $521K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 8,467 | $515K |
| 99283 | Emergency room visit (moderate) | <1% | 11,951 | $511K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 3,108 | $507K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 40,912 | $491K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 3,334 | $470K |
| 76801 | <1% | 15,112 | $463K | |
| 93325 | <1% | 32,274 | $445K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 15,840 | $435K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 10,502 | $412K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 29,830 | $402K |
| 93304 | <1% | 11,011 | $398K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 641 | $381K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 10,125 | $357K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 45,653 | $346K |
| 93320 | <1% | 15,814 | $345K | |
| 88307 | <1% | 7,846 | $343K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 26,345 | $329K |
| 74018 | <1% | 58,755 | $328K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,904 | $320K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 18,342 | $301K |
| 95720 | <1% | 2,822 | $286K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 2,807 | $285K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 4,627 | $277K |
| 20610 | <1% | 6,560 | $272K | |
| 59025 | Fetal non-stress test | <1% | 23,699 | $257K |
| 99460 | <1% | 5,939 | $240K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 3,055 | $237K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12,931 | $235K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 9,533 | $227K |
| 69210 | <1% | 8,608 | $224K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 3,712 | $205K |
| 90837 | Psychotherapy session, about an hour | <1% | 4,107 | $200K |
| 76830 | Ultrasound, transvaginal | <1% | 7,663 | $198K |
| 73630 | <1% | 23,102 | $198K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 8,206 | $195K |
| 95951 | <1% | 1,248 | $165K | |
| 59430 | <1% | 1,754 | $161K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 4,609 | $157K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,030 | $152K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 3,196 | $151K |
| 54300 | <1% | 501 | $150K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12,239 | $147K |
| 88342 | <1% | 7,420 | $145K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 624 | $144K |
| 88141 | <1% | 8,255 | $143K | |
| 31575 | <1% | 2,017 | $143K | |
| 93975 | <1% | 1,995 | $124K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,776 | $122K |
| 49083 | <1% | 919 | $119K | |
| 73610 | <1% | 13,985 | $117K | |
| 95816 | <1% | 2,251 | $113K | |
| 93321 | <1% | 11,315 | $110K | |
| 01961 | <1% | 602 | $109K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,621 | $108K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,658 | $106K |
| 71250 | <1% | 2,806 | $105K | |
| 96113 | <1% | 874 | $104K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,198 | $101K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,929 | $100K |
| 96112 | <1% | 1,214 | $97K | |
| 93000 | <1% | 6,548 | $96K | |
| 73130 | <1% | 11,018 | $94K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 4,539 | $93K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 4,454 | $92K |
| 73562 | <1% | 10,710 | $92K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,745 | $92K |
| 93970 | <1% | 2,321 | $91K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 329 | $90K |
| 92060 | <1% | 6,696 | $90K | |
| 76770 | <1% | 3,565 | $84K | |
| 99385 | <1% | 1,233 | $78K | |
| 93298 | <1% | 4,369 | $75K | |
| 76642 | <1% | 3,468 | $74K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 364 | $70K |
| 95811 | <1% | 453 | $69K | |
| 99220 | <1% | 1,185 | $69K | |
| 99462 | <1% | 3,202 | $67K | |
| 74183 | <1% | 490 | $64K | |
| 55175 | <1% | 526 | $60K | |
| 73030 | <1% | 7,985 | $58K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 2,406 | $58K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,552 | $57K |
| 54360 | <1% | 154 | $56K | |
| 95251 | <1% | 2,638 | $56K | |
| 93793 | <1% | 12,174 | $55K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 1,271 | $55K |
| 11043 | <1% | 632 | $53K | |
| 93971 | <1% | 1,690 | $51K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 941 | $50K |
| 88304 | <1% | 3,613 | $49K | |
| 54161 | <1% | 725 | $48K | |
| 73110 | <1% | 5,536 | $48K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,675 | $48K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 710 | $47K |
| 72100 | <1% | 5,522 | $47K | |
| 74019 | <1% | 5,068 | $46K | |
| 64615 | <1% | 728 | $45K | |
| 99221 | <1% | 1,070 | $45K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 4,011 | $43K |
| 64642 | <1% | 529 | $42K | |
| 42830 | <1% | 424 | $40K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,597 | $39K |
| 94010 | <1% | 4,727 | $37K | |
| 88189 | <1% | 815 | $36K | |
| 93227 | <1% | 2,133 | $36K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 2,899 | $35K |
| 76820 | <1% | 1,699 | $35K | |
| 94729 | <1% | 3,620 | $35K | |
| 81025 | <1% | 6,312 | $34K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 993 | $33K |
| 90474 | <1% | 3,909 | $32K | |
| 81003 | <1% | 18,615 | $31K | |
| 76506 | <1% | 1,466 | $31K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,341 | $30K |
| 73564 | <1% | 2,660 | $30K | |
| 96040 | <1% | 2,007 | $28K | |
| 77066 | Tomosynthesis, mammo | <1% | 741 | $27K |
| 59514 | <1% | 65 | $27K | |
| 92551 | <1% | 3,398 | $27K | |
| 99219 | <1% | 364 | $27K | |
| 72082 | <1% | 1,814 | $26K | |
| 25600 | <1% | 131 | $25K | |
| 93294 | <1% | 1,141 | $25K | |
| 95800 | <1% | 115 | $25K | |
| 93976 | <1% | 573 | $24K | |
| 99051 | <1% | 1,714 | $22K | |
| 95886 | <1% | 762 | $22K | |
| 95819 | <1% | 417 | $22K | |
| 92134 | <1% | 4,345 | $21K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 421 | $21K |
| 84165 | <1% | 6,789 | $21K | |
| 94060 | <1% | 1,762 | $21K | |
| 86334 | <1% | 3,952 | $21K | |
| 94618 | <1% | 2,961 | $21K | |
| 99404 | <1% | 512 | $20K | |
| 90785 | <1% | 8,596 | $19K | |
| 88341 | <1% | 471 | $19K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 500 | $19K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 121 | $18K |
| 95806 | <1% | 404 | $18K | |
| 64721 | <1% | 94 | $18K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 12,833 | $18K |
| 00731 | <1% | 462 | $18K | |
| 11721 | <1% | 1,844 | $18K | |
| 01922 | <1% | 172 | $18K | |
| 64643 | <1% | 239 | $17K | |
| 99226 | <1% | 537 | $16K | |
| 99402 | <1% | 663 | $16K | |
| 88302 | <1% | 978 | $16K | |
| 99417 | Prolong home eval add 15m | <1% | 434 | $16K |
| 70496 | <1% | 204 | $15K | |
| 93244 | <1% | 913 | $15K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,750 | $15K |
| 0072A | <1% | 550 | $14K | |
| 0071A | <1% | 578 | $14K | |
| 93295 | <1% | 578 | $13K | |
| 99350 | Prolong home eval add 15m | <1% | 331 | $13K |
| 31231 | <1% | 154 | $12K | |
| 70498 | <1% | 165 | $12K | |
| 92201 | <1% | 1,375 | $12K | |
| 76825 | <1% | 283 | $12K | |
| 99173 | <1% | 5,777 | $11K | |
| 99407 | <1% | 678 | $11K | |
| 73140 | <1% | 1,378 | $10K | |
| 31622 | <1% | 76 | $10K | |
| 99386 | <1% | 127 | $10K | |
| 94727 | <1% | 1,257 | $10K | |
| 90961 | <1% | 507 | $10K | |
| 73221 | <1% | 135 | $10K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13,299 | $10K |
| 99459 | <1% | 1,344 | $9K | |
| 87634 | <1% | 204 | $9K | |
| 93016 | <1% | 838 | $9K | |
| 94726 | <1% | 798 | $9K | |
| 73502 | <1% | 961 | $9K | |
| 77072 | <1% | 1,476 | $9K | |
| 99201 | <1% | 351 | $8K | |
| 67311 | <1% | 31 | $8K | |
| 73560 | <1% | 1,365 | $8K | |
| 73080 | <1% | 939 | $8K | |
| 95782 | <1% | 42 | $8K | |
| 72040 | <1% | 895 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 926 | $8K |
| 0004A | <1% | 406 | $8K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 76 | $8K |
| 92250 | <1% | 938 | $7K | |
| 99497 | <1% | 730 | $7K | |
| 92511 | <1% | 80 | $7K | |
| 77062 | <1% | 428 | $7K | |
| 73590 | <1% | 1,040 | $7K | |
| 00126 | <1% | 133 | $7K | |
| 77061 | <1% | 437 | $7K | |
| 93018 | <1% | 988 | $7K | |
| 0002A | <1% | 500 | $7K | |
| 54150 | <1% | 55 | $7K | |
| 76942 | <1% | 245 | $7K | |
| 87807 | <1% | 551 | $6K | |
| 76827 | <1% | 285 | $6K | |
| 95718 | <1% | 103 | $6K | |
| 92083 | <1% | 472 | $6K | |
| 72197 | <1% | 43 | $6K | |
| 99381 | <1% | 131 | $6K | |
| 90686 | <1% | 5,817 | $6K | |
| 72141 | <1% | 68 | $5K | |
| 70491 | <1% | 71 | $5K | |
| 74230 | <1% | 321 | $5K | |
| 99292 | <1% | 116 | $5K | |
| 0001A | <1% | 471 | $5K | |
| 43235 | <1% | 41 | $5K | |
| 73521 | <1% | 513 | $5K | |
| 00920 | <1% | 43 | $5K | |
| 91200 | <1% | 490 | $5K | |
| 76813 | <1% | 137 | $4K | |
| 73090 | <1% | 601 | $4K | |
| 70486 | <1% | 89 | $4K | |
| 88313 | <1% | 254 | $4K | |
| 97802 | <1% | 315 | $4K | |
| 0054A | <1% | 129 | $4K | |
| 0003A | <1% | 353 | $4K | |
| 99225 | <1% | 159 | $4K | |
| 92226 | <1% | 384 | $3K | |
| 92015 | Determination of refractive state | <1% | 14,971 | $3K |
| 14040 | <1% | 14 | $3K | |
| 95813 | <1% | 76 | $3K | |
| 20611 | <1% | 49 | $3K | |
| 75561 | <1% | 31 | $3K | |
| 93451 | <1% | 27 | $3K | |
| 92285 | <1% | 492 | $3K | |
| 36558 | <1% | 14 | $3K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 124 | $3K |
| 88112 | <1% | 167 | $3K | |
| 99478 | <1% | 36 | $3K | |
| 85097 | <1% | 91 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 81 | $3K |
| 00811 | <1% | 59 | $3K | |
| 95913 | <1% | 45 | $3K | |
| 76536 | <1% | 150 | $3K | |
| 93750 | <1% | 4,947 | $2K | |
| 31579 | <1% | 31 | $2K | |
| 92133 | <1% | 459 | $2K | |
| 77080 | <1% | 228 | $2K | |
| 99383 | <1% | 27 | $2K | |
| 85060 | <1% | 2,255 | $2K | |
| 70544 | <1% | 40 | $2K | |
| 0124A | <1% | 88 | $2K | |
| 77427 | <1% | 34 | $2K | |
| 00140 | <1% | 28 | $2K | |
| 11750 | <1% | 18 | $2K | |
| 90677 | <1% | 778 | $2K | |
| 01926 | <1% | 12 | $2K | |
| 99422 | <1% | 1,132 | $2K | |
| 43259 | <1% | 12 | $2K | |
| 99490 | Ccm add 20min | <1% | 371 | $2K |
| 99354 | <1% | 643 | $2K | |
| 92567 | <1% | 181 | $2K | |
| 96127 | <1% | 258 | $2K | |
| 17110 | <1% | 30 | $2K | |
| 92557 | <1% | 83 | $2K | |
| 78816 | <1% | 19 | $1K | |
| 26720 | <1% | 12 | $1K | |
| 62322 | <1% | 16 | $1K | |
| 99451 | <1% | 83 | $1K | |
| 30901 | <1% | 13 | $1K | |
| 72110 | <1% | 161 | $1K | |
| 99384 | <1% | 15 | $1K | |
| 96156 | <1% | 35 | $1K | |
| 11730 | <1% | 29 | $1K | |
| 92587 | <1% | 145 | $1K | |
| 90945 | <1% | 41 | $1K | |
| 77049 | <1% | 13 | $1K | |
| 92228 | <1% | 552 | $1K | |
| 92225 | <1% | 93 | $1K | |
| 11056 | <1% | 64 | $1K | |
| 52000 | <1% | 13 | $1K | |
| 0064A | <1% | 50 | $1K | |
| 57454 | <1% | 18 | $1K | |
| 74240 | <1% | 39 | $1K | |
| 11765 | <1% | 20 | $998.94 | |
| 20550 | <1% | 25 | $988.81 | |
| 93990 | <1% | 68 | $986.79 | |
| 80305 | <1% | 117 | $946.15 | |
| 99403 | <1% | 25 | $912.63 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 538 | $905.81 |
| 99442 | <1% | 72 | $876.78 | |
| 99421 | <1% | 560 | $842.45 | |
| 94664 | <1% | 180 | $822.25 | |
| 76937 | <1% | 172 | $818.32 | |
| 73552 | <1% | 103 | $817.09 | |
| 99349 | <1% | 34 | $812.14 | |
| 74241 | <1% | 28 | $762.77 | |
| 99188 | <1% | 53 | $756.83 | |
| 93356 | <1% | 38 | $743.81 | |
| 95911 | <1% | 14 | $718.33 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 161 | $697.73 |
| 97803 | <1% | 63 | $690.45 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 56 | $687.22 |
| 96101 | <1% | 23 | $686.25 | |
| 99464 | <1% | 13 | $657.52 | |
| 97760 | <1% | 48 | $654.58 | |
| 96132 | <1% | 38 | $653.01 | |
| 0053A | <1% | 17 | $622.28 | |
| 58300 | <1% | 12 | $590.16 | |
| 00142 | <1% | 50 | $582.61 | |
| 99177 | <1% | 1,580 | $561.19 | |
| 0034A | <1% | 31 | $560.60 | |
| 90863 | <1% | 138 | $538.78 | |
| 96131 | <1% | 15 | $537.80 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 12 | $531.75 |
| 96136 | <1% | 50 | $529.20 | |
| 29540 | <1% | 28 | $511.95 | |
| 88312 | <1% | 27 | $511.93 | |
| 71271 | <1% | 30 | $503.80 | |
| 99443 | <1% | 38 | $472.51 | |
| 96130 | <1% | 20 | $440.46 | |
| 0013A | <1% | 13 | $404.46 | |
| 99152 | <1% | 163 | $403.97 | |
| 76818 | <1% | 13 | $397.24 | |
| 94799 | <1% | 28 | $396.46 | |
| 99423 | <1% | 166 | $391.14 | |
| 70250 | <1% | 55 | $378.62 | |
| 51701 | <1% | 16 | $346.02 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 942 | $345.55 |
| 20605 | <1% | 15 | $342.73 | |
| 93042 | <1% | 182 | $339.70 | |
| 74328 | <1% | 12 | $334.61 | |
| 76870 | <1% | 13 | $320.62 | |
| 93297 | <1% | 70 | $306.54 | |
| 99358 | Prolong nursin fac eval 15m | <1% | 206 | $300.61 |
| 0082A | <1% | 15 | $300.16 | |
| 92202 | <1% | 44 | $299.21 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 57 | $289.83 |
| 88311 | <1% | 111 | $273.87 | |
| 77073 | <1% | 26 | $266.02 | |
| 72020 | <1% | 58 | $261.85 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,620 | $249.15 |
| 98960 | <1% | 58 | $239.17 | |
| 99406 | <1% | 29 | $236.67 | |
| 90962 | <1% | 20 | $235.71 | |
| 72050 | <1% | 27 | $235.22 | |
| 11057 | <1% | 12 | $231.47 | |
| 93922 | <1% | 14 | $211.14 | |
| 96102 | <1% | 20 | $210.48 | |
| 86308 | <1% | 39 | $183.05 | |
| 77001 | <1% | 14 | $172.24 | |
| 99050 | <1% | 14 | $171.36 | |
| 86077 | <1% | 161 | $164.53 | |
| 96161 | <1% | 54 | $158.24 | |
| 88300 | <1% | 35 | $157.67 | |
| 88720 | <1% | 45 | $155.56 | |
| 84166 | <1% | 27 | $151.58 | |
| 72170 | <1% | 33 | $150.69 | |
| 99441 | <1% | 13 | $143.63 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 753 | $139.61 |
| 96137 | <1% | 15 | $138.00 | |
| 76776 | <1% | 12 | $129.54 | |
| 94728 | <1% | 14 | $126.03 | |
| 96138 | <1% | 21 | $104.40 | |
| 72120 | <1% | 16 | $104.17 | |
| 96380 | <1% | 15 | $93.72 | |
| 81002 | <1% | 44 | $80.06 | |
| 82962 | <1% | 39 | $76.95 | |
| 1159F | <1% | 653,537 | $74.93 | |
| 90694 | <1% | 12 | $71.68 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 144 | $61.20 |
| 95874 | <1% | 14 | $45.84 | |
| 3044F | <1% | 13,835 | $30.00 | |
| 90656 | <1% | 395 | $21.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16 | $19.64 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 769 | $18.81 |
| 90970 | <1% | 24 | $11.28 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 370 | $9.67 |
| J3490 | Unclassified drugs | <1% | 15 | $8.35 |
| 96160 | <1% | 167 | $6.04 | |
| 86335 | <1% | 13 | $1.81 | |
| 3078F | <1% | 101,064 | $1.35 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 93 | $0.43 |
| 3079F | <1% | 37,026 | $0.20 | |
| 90633 | <1% | 2,569 | $0.11 | |
| 90648 | <1% | 3,863 | $0.01 | |
| 3008F | 0% | 238,055 | $0.00 | |
| 4010F | 0% | 17,595 | $0.00 | |
| 3074F | 0% | 126,076 | $0.00 | |
| 90723 | 0% | 2,759 | $0.00 | |
| 3075F | 0% | 9,710 | $0.00 | |
| 90744 | 0% | 1,097 | $0.00 | |
| 90651 | 0% | 931 | $0.00 | |
| 90698 | 0% | 3,112 | $0.00 | |
| 90680 | 0% | 3,696 | $0.00 | |
| 3066F | 0% | 1,515 | $0.00 | |
| 91307 | 0% | 496 | $0.00 | |
| 3061F | 0% | 326 | $0.00 | |
| 3080F | 0% | 3,111 | $0.00 | |
| 91301 | 0% | 14 | $0.00 | |
| 91305 | 0% | 168 | $0.00 | |
| 0031A | 0% | 83 | $0.00 | |
| 99000 | 0% | 370 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 82 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 50 | $0.00 |
| 1111F | 0% | 134 | $0.00 | |
| 90647 | 0% | 174 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 780 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 49 | $0.00 |
| 90696 | 0% | 41 | $0.00 | |
| 96111 | 0% | 129 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 113 | $0.00 |
| 90716 | 0% | 57 | $0.00 | |
| 90620 | 0% | 50 | $0.00 | |
| 2023F | 0% | 14 | $0.00 | |
| 99355 | 0% | 23 | $0.00 | |
| 91303 | 0% | 14 | $0.00 | |
| 3052F | 0% | 14 | $0.00 | |
| 1160F | 0% | 424,449 | $0.00 | |
| 90670 | 0% | 6,681 | $0.00 | |
| 3077F | 0% | 7,507 | $0.00 | |
| 90734 | 0% | 951 | $0.00 | |
| 90685 | 0% | 221 | $0.00 | |
| 2025F | 0% | 138 | $0.00 | |
| 90715 | 0% | 119 | $0.00 | |
| 3046F | 0% | 89 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 25 | $0.00 |
| 0298T | 0% | 190 | $0.00 | |
| 99078 | 0% | 188 | $0.00 | |
| 91300 | 0% | 606 | $0.00 | |
| 91312 | 0% | 70 | $0.00 | |
| 90707 | 0% | 95 | $0.00 | |
| 90700 | 0% | 65 | $0.00 | |
| 0295T | 0% | 15 | $0.00 | |
| 92504 | 0% | 17 | $0.00 | |
| 90710 | 0% | 41 | $0.00 | |
| 90662 | 0% | 84 | $0.00 | |
| 1158F | 0% | 12 | $0.00 | |
| 3051F | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOLLOY, JAMES (CHIEF FINANCIAL OFFICER)